ALDOMET

This brand name is authorized in Brazil, Ecuador, Spain, France, Hong Kong, Ireland, Japan, Mexico, United Kingdom, South Africa

Active ingredients

The drug ALDOMET contains one active pharmaceutical ingredient (API):

1 Alphamethyldopa UNII 56LH93261Y - METHYLDOPA

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. Read about Alphamethyldopa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02AB	Methyldopa	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting
Discover more medicines within C02AB
C02AB01	Methyldopa (levorotatory)	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1629R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505609001119416, 505609002115317
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H6970913, H6980913
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 37932, 53587
Country: FR	Base de données publique des médicaments	Identifier(s): 60578560, 64651319
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13703, 13736, 178957, 178959
Country: HK	Department of Health Drug Office	Identifier(s): 01954
Country: JP	医薬品医療機器総合機構	Identifier(s): 2145001F1027, 2145001F2040
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 57518
Country: ZA	Health Products Regulatory Authority	Identifier(s): C/7.1.3/205